Continuity Biosciences appoints Vicky Papoutsis to board amid clinical push

The clinical-stage biotech said the TerSera Therapeutics strategy executive joins as it advances a pancreatic cancer program in the clinic and expands partnership activity.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.